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Key points
 Sleep restriction has previously been associated with the loss of muscle mass in both human
and animal models.
 The rate ofmyofibrillar protein synthesis (MyoPS) is a key variable in regulating skeletalmuscle
mass and can be increased by performing high-intensity interval exercise (HIIE), although the
effect of sleep restriction on MyoPS is unknown.
 In the present study, we demonstrate that participants undergoing a sleep restriction protocol
(five nights, with 4 h in bed each night) had lower rates of skeletal muscle MyoPS; however,
rates of MyoPS were maintained at control levels by performing HIIE during this period.
 Our data suggest that the lower rates of MyoPS in the sleep restriction group may contribute
to the detrimental effects of sleep loss on muscle mass and that HIIE may be used as an
intervention to counteract these effects.
Abstract The present study aimed to investigate the effect of sleep restriction, with or
without high-intensity interval exercise (HIIE), on the potential mechanisms underpinning
previously-reported sleep-loss-induced reductions to muscle mass. Twenty-four healthy, young
men underwent a protocol consisting of two nights of controlled baseline sleep and a five-night
intervention period. Participants were allocated into one of three parallel groups,matched for age,
V˙O2 peak , body mass index and habitual sleep duration; a normal sleep (NS) group [8 h time in bed
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(TIB) each night], a sleep restriction (SR) group (4 h TIB each night), and a sleep restriction and
exercise group (SR+EX, 4 h TIB each night, with three sessions of HIIE). Deuterium oxide was
ingested prior to commencing the study andmuscle biopsies obtained pre- and post-intervention
were used to assess myofibrillar protein synthesis (MyoPS) and molecular markers of protein
synthesis and degradation signalling pathways. MyoPS was lower in the SR group [fractional
synthetic rate (% day–1), mean ± SD, 1.24 ± 0.21] compared to both the NS (1.53 ± 0.09)
and SR+EX groups (1.61 ± 0.14) (P < 0.05). However, there were no changes in the purported
regulators of protein synthesis (i.e. p-AKTser473 and p-mTORser2448) and degradation (i.e. Foxo1/3
mRNA and LC3 protein) in any group. These data suggest that MyoPS is acutely reduced by
sleep restriction, although MyoPS can be maintained by performing HIIE. These findings may
explain the sleep-loss-induced reductions in muscle mass previously reported and also highlight
the potential therapeutic benefit of HIIE to maintain myofibrillar remodelling in this context.
(Received 16 August 2019; accepted after revision 16 January 2020; first published online 20 February 2020)
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Introduction
Sleep plays a key role in many physiological and cognitive
functions, and it is recommended that adults obtain
between 7 and 9 h of sleep each night (Spiegel et al.
1999; Van Dongen et al. 2003; National Sleep Foundation,
2015). Sleep has also been causatively implicated in the
maintenance of muscle mass (Nedeltcheva et al. 2010;
Dattilo et al. 2012), with an increased likelihood of
both sarcopenia and lower total skeletal muscle mass
in those reporting insufficient (i.e. <7 h per night) or
poor sleep quality (Chien et al. 2015; Buchmann et al.
2016; Hu et al. 2017). During periods of energy deficit, a
disproportionately greater loss of muscle mass has been
reported in humans following sleep restriction [5.5 h time
in bed (TIB) each night for 14 days] compared to normal
sleep (8.5 h TIB each night for 14 days) (Nedeltcheva
et al. 2010). In animal models, muscle atrophy has also
been observed following sleep deprivation (i.e. >24 h of
extended wakefulness) (Dattilo et al. 2012; Monico-Neto
et al. 2015a; Monico-Neto et al. 2015b; de Sa Souza et al.
2016); however, the potential mechanisms by which sleep
restriction may lead to muscle atrophy have not been
comprehensively studied in humans.
Changes in muscle mass are, in the short-term (i.e.
days to weeks), largely determined by the balance between
the rates of muscle protein synthesis (MPS) and muscle
protein breakdown (MPB) (Rennie, 1985; Gibson et al.
1987). Previous reports suggest that sleep deprivationmay
influence these processes. Indeed, protein catabolism in
humans (determined by urea excretion) was increased
following 72 h of sleep deprivation (Kant et al. 1984),
although whether this was accompanied by changes
in muscle protein turnover is unknown. Interventions
known to induce loss of muscle mass (such as muscle
disuse, limb immobilization and step reduction) suggest
that reductions in MPS, and specifically myofibrillar
protein synthesis (MyoPS), rather than increases in MPB,
underlie these changes (Symons et al. 2009; Breen et al.
2013; Rudrappa et al. 2016). Accordingly, a reduction in
MPS, and potentially MyoPS, may underpin reductions
to muscle mass induced by sleep restriction. However, a
potential catabolic influence of sleep restriction cannot be
excluded given previous findings of increased autophagy
and ubiquitination markers in rodent sleep deprivation
studies (Monico-Neto et al. 2015a; de Sa Souza et al. 2016).
Nonetheless, no study to date has investigated the effects of
sleep restriction onMPS, in whole or fractionated human
skeletalmuscle, or thepotential catabolic influenceof sleep
restriction on markers of MPB.
At the molecular level, protein synthesis is regulated
via the activation of the AKT-mTOR-p70S6K signalling
pathway, which subsequently leads to increases in strength
and muscle mass over time (Bodine et al. 2001).
However, little is known about how sleep restriction
may influence these pathways. Following 96 h of sleep
deprivation, either no change in p-mTORser2448 and
p-p70S6Kthr389 (Monico-Neto et al. 2015a) or an increase
in p-mTORser2448 and p-4EBP1ser65 (de Sa Souza et al.
2016) were observed in rodent skeletal muscle. Although
MPS is considered the driving force underpinning changes
in muscle mass, MPB may also contribute to these
changes. Molecular markers of the ubiquitin proteasome
system (UPS) (i.e. FOXO1/3, MuRF1 and MAFbx), as
well as the autophagy signalling pathways (i.e. LC3 and
p62/SQSTM1) that lead to protein degradation, are often
measured as a proxy for protein degradation (Tipton et al.
2018). In rodents, 96 h of sleep deprivation elevated levels
of ubiquitinated proteins, markers of protein degradation
(e.g. p-FOXO3Ser253) and autophagy pathways (e.g. LC3
and p62/SQSTM1) and also induced muscle atrophy
(Monico-Neto et al. 2015a; de Sa Souza et al. 2016).
However, such mechanisms in human models reflecting
levels of sleep loss commonly experienced in society are
yet to be investigated.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Although resistance exercise is regarded as the most
potent stimulus to induce skeletal muscle protein
synthesis, high-intensity interval exercise (HIIE) is also
capable of inducing muscle protein synthesis, and its
associated signalling pathways (Miller et al. 2005; Di
Donato et al. 2014; Bell et al. 2015). Given the increasing
prevalence of inadequate sleep in modern society (Ford
et al. 2015) and the important metabolic and structural
roles of skeletal muscle, there are clear health implications
to mitigating reductions in muscle mass resulting from
inadequate sleep. Given the potency of the stimulus
provided by HIIE to stimulate MyoPS (Bell et al. 2015)
and its time-efficient nature (Hood et al. 2011), as well as
its other proven clinical benefits (such as improvements
in insulin sensitivity and oxidative capacity) (Little et al.
2011; Saner et al. 2018), HIIE may be a potential
therapeutic intervention to counteract the detrimental
effects of sleep restriction on muscle quality.
The effects of sleep restriction and HIIE on MyoPS and
its associated signalling pathways have not previously been
investigated in humans. Consequently, the present study
aimed to determine the potential mechanisms by which
sleep restriction may contribute to previously reported
reductions in muscle mass. Specifically, the study used a
previously published model of sleep restriction (i.e. five
nights, with 4 h TIB each night) (Reynolds et al. 2012) to
investigate the effect of sleep restriction, with or without
three sessions ofHIIE, on the rate ofMyoPS and associated
molecular signalling pathways. We hypothesized that the
rate of MyoPS would be lower in the sleep restriction
group and this would be reflected by changes in the
molecular signalling pathways associated with MPS and
MPB, whereas performing three sessions of HIIE would
attenuate this effect.
Methods
Ethical approval
All procedures involved conform to the standards set by
the latest revision of the Declaration of Helsinki (except
for registration in a database) and were approved by the
Victoria University Human Research Ethics Committee
(HRE15-294).
Participants
Twenty-four healthy, recreationally-active men, aged
between 18 and 40 years of age, volunteered to participate,
having had all procedures and risks explained, and
provided their written informed consent. Participants
were screened to determine their eligibility, as well
as to rule out any pre-existing medical conditions
that may have precluded their participation (e.g.
cardiovascular, metabolic or musculoskeletal problems).
Table 1. Baseline characteristics of participants
NS
(n = 8)
SR
(n = 8)
SR+EX
(n = 8)
Age (years) 24 ± 4 25 ± 5 24 ± 4
Height (cm) 177 ± 8 179 ± 6 179 ± 7
Mass (kg) 78.7 ± 13.3 74.5 ± 11.7 80.2 ± 9.5
BMI 25.2 ± 3.6 23.3 ± 3.0 24.6 ± 2.5
V˙O2 peak (mL kg
−1
min−1)
43.7 ± 9.7 47.2 ± 6.7 48.0 ± 5.0
W˙Peak (W) 319 ± 59 330 ± 44 362 ± 48
Habitual sleep
duration (min)
457 ± 45 428 ± 44 437 ± 39
Values are the mean ± SD. There were no statistically significant
differences between the three groups for any of the baseline
characteristics. BMI, body mass index.
Eligible participants included in the study were (i) not
taking any medications before and during the study;
(ii) not performing shift work (within the previous
three months); (iii) had regular sleeping habits and
no previously-diagnosed sleep disorders; (iv) had not
travelled overseas in the previous two months; and (v)
had a body mass index between 19 and 30 kg m–2. Prior
to commencing the study, 1 week of habitual sleep was
monitored via wristwatch actigraphy and sleep diaries;
participants who averaged <6 or >9 h sleep per night
during the monitoring period were also excluded from
the study.
Study setting
The study was conducted in a temperature-controlled
sleep laboratory with the capacity for three participants
to complete the study at any one time, each within their
own bedroom. Participants were monitored at all times
throughout the study by a member of the research team
to ensure adherence to the protocol.
Study overview
Following the initial screening procedures, eligible
participants attended the exercise physiology laboratory
for baseline assessments of anthropometricmeasurements
(i.e. height and body mass), and aerobic fitness (V˙O2 peak )
determined from a graded exercise test (GXT). In a
counterbalanced order, participants were then assigned
to one of three experimental groups, matched for age,
body mass index, habitual sleep duration, and V˙O2 peak :
normal sleep (NS, n = 8), sleep restriction (SR, n = 8)
or sleep restriction and exercise (SR+EX, n = 8). Base-
line participant characteristics for the three groups are
shown in Table 1. One week prior to beginning the study
participants also provided a pre-study, resting skeletal
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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muscle biopsy, to determine baseline levels of deuterium
oxide (D2O) enrichment.
The experimental component of the study consisted of
an eight-night stay within the sleep laboratory. All groups
completed two initial nights of baseline sleep (8 h TIB,
23.00 h to 07.00 h), followed by a five-night intervention
period, during which the NS group spent 8 h TIB (23.00 h
to 07.00 h), whereas both SR and SR+EX spent 4 hTIB per
night (03.00 h to 07.00 h). Between 23.00 h and 03.00 h,
lighting was dimmed to below 15 lux to reduce the effect
of lighting on circadian rhythms (Duffy & Wright, 2005).
The SR+EX group also performed three exercise sessions
during the interventionperiodondays 4, 5 and6at 10.00h.
Following the intervention period, all groups completed
a final night of ad libitum recovery sleep. An overview of
the study protocol is shown in Fig. 1.
To assess MyoPS and molecular markers of protein
synthesis and degradation pathways, two additional
resting skeletal muscle biopsies were sampled during
the experimental testing sessions, at 10.00 h on both
day 3 (following two nights of baseline sleep) and day
8 (following the final night of the sleep intervention).
Throughout the study, participants were provided with a
standardized diet consisting of fixed proportions (relative
to bodymass) of carbohydrates (4.5 g kg−1 day−1), protein
(1.5 g kg−1 day−1) and fat (1 g kg−1.d−1). All meal times
(six throughout the day) were kept constant throughout
the study and participants were requested to eat all food
provided.Dietary intakewas replicatedon thedaysprior to
both experimental sessions.Caffeine intakewasprohibited
throughout the study. Participants were asked to match
their habitual step counts by walking outside of the facility
at designated periods throughout the day, accompanied by
a member of the research staff. Waking hours were spent
watching television, reading, working on a computer or
talking to the staff.
Experimental procedures
Sleep monitoring. Sleep was assessed using wrist-watch
activity devices worn on the non-dominant wrist
(Actiwatch 2; Philips Respironics, Murrysville, PA, USA)
with device activity sensitivity set to medium (40 activity
counts per 30 s epoch) (Kosmadopoulos et al. 2014;
Sargent et al. 2016), collected at 32 Hz and scored using
a validated automated scoring algorithm (Oakley, 1997).
These devices were used to objectively measure total sleep
time (TST) obtained both habitually (prior to the study)
and throughout the study. A member of the research
team recorded the exact time that bedroom lights were
switched on and off, allowing participants the designated
sleep opportunity each night.
Physical activity monitoring. Throughout the study, and
during 1 week prior (for habitual step-count), daily step
Table 2. Habitual and sleep study step counts for participants in
each group
Step count NS SR SR+EX
Habitual 12260 ± 3964 10965 ± 2136 11831 ± 919
Study 10652 ± 2476 10033 ± 1839 10953 ± 2316
Values are the mean ± SD. There were no significant differences
between daily step counts, habitually and within the study
protocol, in any of the groups.
counts were monitored using commercially available and
validated step-counting applications on the participants’
personal mobile phone devices (i-Health app; Apple Inc.,
Cupertino, CA, USA; and Samsung Health, Samsung
Electronics Co., Ltd., Suwon, South Korea) (Hochsmann
et al. 2018). Participants were encouraged to replicate their
habitual daily step counts throughout the study protocol
(Table 2). Participants were supervised at all times, and
instructed to avoid any additional moderate or vigorous
physical activity throughout the study.
GXT. A baseline assessment of aerobic fitness (i.e. peak
oxygen uptake (V˙O2 peak ) and peak power (W) (W˙Peak) was
performed on an electronically-braked cycle ergometer
(Excalibur, V2.0; Lode, Groningen, The Netherlands).
Following a standardized warm-up (5 min at 30 W),
participants cycled against an incremental ramp protocol
where the resistance continually increased by 1 W every
2 s (30 Wmin−1) until volitional exhaustion (i.e. cadence
fell below 60 rpm). Expired air was continuously analysed
for O2 and CO2 concentrations via a gas analyser (Moxus
2010; AEI Technologies, Pittsburgh, PA, USA), which was
calibrated immediately before each test.
HIIE. The HIIE protocol was adapted from a previous
study (Little et al. 2010) and consisted of 10× 60 s intervals
performed on a cycle ergometer (RacerMate; Velotron,
Seattle, WA, USA) at 90% of each participant’s W˙peak.
Each interval was interspersed with 75 s of active recovery
(at 60 W). Each session started with a 3 min warm up
at 60 W. Heart rate (HR) (FT1; Polar, Kempele, Finland)
and ratings of perceived exertion (RPE) (Borg, 1970) were
recorded at the end of each interval. The mean power
per interval was 318 ± 53 W, mean HR throughout the
protocol was 156 ± 13 bpm, peak HR was 182 ± 12 bpm,
and the average RPE per interval was 15 ± 2 AU.
Muscle biopsies. One week prior to commencing the
study, and during the experimental sessions (day 3 and
day 8), muscle biopsies were sampled from the vastus
lateralis muscle of the same leg, using a suction-modified
Bergstro¨m needle, under local anaesthesia of the skin and
fascia (1% lidocaine). The pre-study biopsy was sampled
at 10.00 h, following an overnight fast, and was used to
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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determine background enrichment of D2O (prior to the
ingestion of the D2O bolus) for the subsequent MyoPS
analysis. The samples collected on days 3 and 8 were also
obtained at 10.00 h, both following an overnight fast. All
samples were immediately frozen in liquid nitrogen and
stored at –80°C for subsequent analyses.
Assessment of MyoPS.
D2O ingestion and saliva sample collection. The fractional
synthetic rate (FSR) of MyoPS was assessed via the
D2O tracer technique as previously reported (Wilkinson
et al. 2014). At 18.00 h on day 1, each participant
ingested 150 mL of D2O (70 atom %; Cambridge Isotope
Laboratories, Tewksbury, MA, USA). Saliva samples were
collected in salivettes prior to D2O ingestion and then on
days 3, 5, 7 and 8 to determine body water enrichment. 2H
enrichmentof salivawasdeterminedby a cavity ring-down
spectroscopy with the use of a liquid isotope analyser
(Picarro L2130-I analyser; Picarro, Santa Clara, CA, USA)
with an automated injection system. Total body water 2H
enrichment was used as a surrogate for plasma alanine 2H
labelling, as previously described (Wilkinson et al. 2014).
The mean body water enrichment [atomic percentage
excess (APE), mean ± SD) throughout the intervention
was 0.18 ± 0.03 APE on day 3, 0.15 ± 0.04 APE on day 5,
0.12 ± 0.03 APE on day 7 and 0.12 ± 0.03 APE on day 8.
Muscle preparation to determine myofibrillar fractional
synthesis rate. Frozenmuscle samples (40 to 60mg) were
homogenized in 500 µl of ice-cold Tris homogenization
buffer (25mMTris-HCl, TritonX-100 (0.5%final volume),
protease inhibitor (catalogue no. 4693116001; Roche,
Basel Switzerland) and phosphatase inhibitor (catalogue
no. 4906845001; Roche). Metal beads were added to
all samples and run at 20 Hz for 40 s in a tissue
homogenizer (Tissue Lyser II; Qiagen, Valencia, CA,
USA). The muscle homogenate was then centrifuged
at 4500 rpm for 10 min at 4°C. The supernatant was
removed and the pellet was used to prepare the myo-
fibrillar fraction as previously described (Burd et al. 2010).
Cation exchange chromatography was then performed
on the myofibrillar samples using columns containing
Dowex resin (Dowex 50wx8-200 ion exchange resin;
Sigma-Aldrich, St Louis, MO, USA) to extract free amino
acids from the myofibrillar fractions (Burd et al. 2010).
The amino acid samples were then derivatized as their
N-acetyl-n-propyl-esters, in accordance with previously
reported protocols (Hector et al. 2018; McGlory et al.
2018).
FSR. The 2H/1H ratio of the myofibrillar samples were
determined using gas chromatography pyrolysis isotope
ratio mass spectrometry (Metabolic Solutions, Nashua,
NH, USA), to assess the incorporation of deuterium into
protein-bound alanine. This was used to assess the FSR
of myofibrillar proteins with the use of the enrichment of
body water, corrected for the mean number of deuterium
moieties incorporated per alanine (i.e. 3.7), as described
previously (Wilkinson et al. 2014), as the surrogate
precursor labelling between subsequent biopsies. Saliva
enrichments were assessed using cavity ring-down
–1 week
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Figure 1. Schematic representation of the study protocol
D2O – deuterium oxide ingestion; R, ad libitum recovery sleep; participant screening refers to medical
questionnaires, exclusion criteria and habitual sleep, as well as physical activity monitoring.
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spectroscopy using methods, as described previously
(Hector et al. 2018; McGlory et al. 2018).
The standard equation (Wilkinson et al. 2014) used to
determine FSR was:
FSR (% day−1) = ((E t1 − E t0)/(E p × time)) × 100
where FSR is the fractional synthetic rate, Et1 is APE day
8, Et0 is APE day 3, Ep is average saliva APE, time is time
between biopsies (days) and APE is the atomic percentage
excess.
Preparation ofwhole-muscle lysates forwestern blotting.
Frozenmuscle (10–20 mg) was homogenized as described
previously (Granata et al. 2016) in an ice-cold lysis buffer
(dilution 1:20 w/v) containing 50 mM Tris, 150 mM
NaCl, 1 mM EDTA, 1% IGEPAL, deionized water and
a protease/phosphatase inhibitor cocktail (Cell Signaling
Technology, Danvers, MA, USA), adjusted to pH 7.4.
Protein concentration was determined in triplicate with
a commercial colorimetric assay (Protein Assay kit-II;
Bio-Rad, Gladesville, NSW, Australia), against bovine
serum albumin standards (A9647; Sigma-Aldrich).
Western blotting. Muscle homogenate was diluted in
4 × Laemmli buffer (0.25 M Tris, 4% SDS, 20% glycerol,
0.015% bromophenol blue and 10% 2-mercaptoethanol)
and equal amounts of total protein (15 or 20 µg) were
loaded in different wells on CriterionTM 4–20% TGX
Stain-FreeTM Precast Gels (Bio-Rad). A stain-free system
(Bio-Rad, Australia) was used as a loading control, with
protein expression normalized to total protein loaded
per lane. Each participant’s samples were loaded into
adjacent lanes on the same gel. Each gel also contained
four to six internal standards of varying dilutions, made
from a mixed homogenate of every sample in equal
concentrations. These standards were used to form a
calibration curve, with density plotted against protein
content. Protein abundance was then calculated from the
measured band intensity for each sample on the gel, using
the linear regression equation from the calibration curve
(Murphy & Lamb, 2013).
Gel electrophoresis was run for 20 min at 80 V and
then for a further 60 to 90 min at 80 to 150 V. Transfer of
proteins from the gel to 0.2 µm polyvinylidene fluoride
membrane at 25 V for 10 min was performed via turbo
transfer (Bio-Rad). Membranes were then blocked in 5%
non-fat dry milk diluted in Tris-buffered saline with 0.1%
Tween-20 (TBST) for 60min. Membranes were washed in
TBST and incubated overnight at 4°Cwith the appropriate
primary antibody, prepared at a 1:1000 dilution in TBST
with 5% bovine serum albumin and 0.02% sodium
azide. The primary antibodies used were from Cell
Signaling Technologies and include total AKT (CST9272),
p-AKTser473 (CST9271), total mTOR (CST2983),
p-mTORser2448 (CST5586), caspase-3 (CST9662),
total p70S6K (CST9202), total TSC2 (CST4308),
p-TSC2thr1462 (CST3617), LC3 (CST3868), p-4EBP1thr37/46
(CST2855) and NFκB (CST8242). The measurement
of p-p70S6Kthr389 protein content could not be assessed
because of issues with respect to obtaining reliable
results with the available antibodies (i.e. CST9205 and
CST9234). Following four TBST washes, the membranes
were then incubated at room temperature with the
appropriate host species-specific secondary antibody for
60 min, before being exposed to a chemiluminescence
solution (Clarity Western ECL; Bio-Rad; or Super-
signal West Femto Maximum Sensitivity Substrate;
Thermo Fisher, Waltham, MA, USA). Images were taken
with a ChemiDoc Imaging System fitted (Bio-Rad).
Densitometry was performed with Image Lab, version 5.0
(Bio-Rad). Images are typically displayed with at least five
bandwidths above and below the band of interest.
Quantitative RT-PCR.
RNA extraction. RNA was extracted from frozen muscle
samples (10–20 mg) by adding 800 µL of TRIzol
(15596-026; Life Technologies, Grand Island, NY, USA)
and a stainless steel metal bead to each sample and using
a homogenizing instrument (Tissue Lyser II; Qiagen)
(Kuang et al. 2018). Prior to storage, separate aliquots
were taken for RNA quantification using a Nanodrop
spectrophotometer (Thermo Fisher) and RNA integrity
testing using an automatedmicrocapillary electrophoresis
system (Experion; Bio-Rad Laboratories, Hercules, CA,
USA). cDNA was synthesized from 1 µg of RNA using
the iScriptTM Reverse transcription supermix for RT-PCR
kit (Bio-Rad Laboratories). DEPC water (180 µL) was
added to all samples following cDNA synthesis and
samples were stored at −20°C. As a result of small
muscle sample collections for one of the participants,
only samples from seven participants in the NS group
were prepared for RT-PCR. Relative mRNA expression
was measured by qPCR (QuantStudio 7 Flex; Applied
Biosystems, Foster City, CA, USA) using SsoAdvanced
Universal SYBR Green Supermix (Bio-Rad). Primers were
designedusingPrimer-BLAST(Ye et al.2012) to include all
splice variants, and were purchased from Sigma-Aldrich.
All reactions were performed in duplicate on 384-well
MicroAmp optical plates (4309849; Applied Biosystems)
using an epMotion M5073 automated pipetting system
(Eppendorf AG, Hamburg, Germany). The total reaction
volume of 5 µL contained cDNA template, 2.5 µL of
2 × mastermix and 0.3 µM or 0.9 µM primers. All assays
ran for 10 min at 95°C, followed by 40 cycles of 15 s at
95°C and 60 s at 60°C.
Primer design and data normalization. The expression of
each target gene was normalized to the geometric mean
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Table 3. RT-PCR primer sequences
Primer name Primer sequence
Product
Size (bp)
Efficiency
(%)
Accession
number
Target genes
Myostatin F – GGAGAAGATGGGCTGAATCCG
R – GCATCGTGATTCTGTTGAGTGC
111 98.9 NM 005259
Murf1 F – CCGTCGAGTGACCAAGGAGA
R – CCAGGATGGCATACAACGTG
80 98.6 NM 032588
Mafbx F – GCAGCTGAACAACATTCAGATCAC
R – CAGCCTCTGCATGATGTTCAGT
97 99.5 NM 058229
Foxo1 F – TGAGGGTTAGTGAGCAGGTTAC
R – GGACTGCTTCTCTCAGTTCCT
73 108.1 NM 002015
Foxo3 F –TTGGTTTGAACGTGGGGAAC
R –TGTGTCAGTTTGAGGGTCTGC
119 91.1 NM 001455.4
Mighty F – CCAACTCCGGAGCAAATTTTTCA
R – TCCGAAGCACAAGCTTCACT
106 94.7 NM 024595
p62/SQSTM1 F – AGAATCAGCTTCTGGTCCATCGG
R – CTTTTCCCTCCGTGCTCCAC
129 103.2 NM_003900.5
Housekeeping genes
B2M F – TGCTGTCTCCATGTTTGATGTATCT
R – TCTCTGCTCCCCACCTCTAAGT
86 98 NM 004048.2
ACTB F – GAGCACAGAGCCTCGCCTTT
R – TCATCATCCATGGTGAGCTGGC
70 107 NM 001101.3
TBP F – CAGTGACCCAGCAGCATCACT
R – AGGCCAAGCCCTGAGCGTAA
205 99 NM 003194.4
F, forward primer; R, reverse primer.
of expression of the three most stably expressed reference
genes, as described previously (Vandesompele et al. 2002;
Kuang et al. 2018), and using the 2−Ct method (where
Ct is the quantification cycle) (Schmittgen & Livak, 2008).
A list of housekeeping and target gene primer sequences
is provided in Table 3.
Statistical analysis
Statistical analyses were conducted using Prism, version
7.03 (GraphPad Software Inc., San Diego, CA, USA).
Pre- to post-intervention changes in gene expression and
protein contentwere assessed for each groupusing amixed
ANOVA with one between-subjects measure (group) and
a within-subjects measure (time). Significant effects of
interaction (group × time), time (pre vs. post) and group
(NS vs. SR vs. SR+EX) are reported where effects are
seen. Where significant effects occurred, Bonferonni post
hoc testing was performed to locate the differences. All
statistical analyses of gene expression and protein content
data were conducted using raw values. Gene expression
data in-text are reported as percent fold-changes from
pre-intervention values (%, mean ± SD) with 95%
confidence interval (CI) from fold-change data (as
a percentage), with the P value from the raw data
reported. Data in the figures represent fold-changes from
pre-intervention values, with individual responses. A
one-way ANOVA was used to assess differences between
groups for the mean actigraphy sleep data and MyoPS
data. All data in the text, figures and tables are presented
as the mean ± SD, and 95% CI with P < 0.05 indicate
statistical significance.
Results
Sleep data
Therewere no between-group differences for baseline TST
[mean ± SD TST (min) of nights 1 and 2, P value,
NS; 448 ± 25 min, SR; 452 ± 17 min, and SR+EX;
459 ± 9 min, P = 0.50]. The NS group showed no
difference in TST between the baseline and intervention
periods [mean ± SD difference (min), 95% CI min,
P value, 1 ± 28 min, 95% CI = –20 to 17 min, P > 0.99].
Both sleep-restricted groups had a reduction in TST
during their respective interventions compared to the
baseline period (SR; –224 ± 20 min, 95% CI = −241
to −203 min, P < 0.001; SR+EX −223 ± 9 min, 95%
CI = −242 to −204 min, P < 0.001). Compared to
the NS group, TST during the intervention period was
significantly reduced in both the SR group (−219± 8min,
95% CI = −236 to −202 min, P < 0.001) and SR+EX
group (−214 ± 8 min, 95% CI = −231.5 to −197 min,
P < 0.001). There were no significant differences in TST
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between the SR and SR+EX groups during the inter-
vention period (−5 ± 3 min, 95% CI = −23 to 12 min,
P = 0.72).
MyoPS
There was a significant difference between groups for
MyoPS throughout the intervention period (P < 0.001).
Compared to the NS group, the myofibrillar protein
FSR was significantly lower [mean ± SD between-group
difference FSR (% day–1), 95% CI, P value] in the SR
group; –0.29 ± 0.08 FSR % day–1, 95% CI [−0.50, −0.09
FSR % day–1], P = 0.004) (Fig. 2). Furthermore, MyoPS
was significantly lower in the SR group compared to
the SR+EX group (−0.37 ± 0.09 FSR % day–1, 95%
CI = −0.58 to −0.17 FSR % day–1, P < 0.001). There
was no difference in MyoPS between the NS and SR+EX
groups (0.08± 0.06 FSR% day–1, 95%CI= −0.29 to 0.12
FSR % day–1, P = 0.95).
Protein synthesis and protein degradation related
mRNA gene expression
There was no significant interaction effect formRNA gene
expression of Foxo1 (P = 0.69), Foxo3 (P = 0.74), Myo-
statin (P = 0.19), Mafbx (P = 0.24), Mighty (P = 0.81)
or p62/SQSTM1 (P = 0.09) compared to pre-intervention
values. Despite there being a significant interaction effect
for Murf1 mRNA gene expression (P = 0.026), post hoc
analyses revealed no difference between groups from pre
to post-intervention (NS: 61 ± 81%, 95% CI = −114 to
−9%, P= 0.25), (SR:−26± 33%, 95%CI= −23 to 75%,
P = 0.27), (SR+EX: −29 ± 35%, 95% CI = −20 to 28%,
P = 0.20) (Fig. 3).
Figure 2. FSR of myofibrillar proteins throughout the sleep
intervention
NS, SR and SR+EX groups. Bars are the mean ± SD. ∗Significant
difference from both NS and SR+EX conditions; one-way ANOVA
(P < 0.05).
Protein synthesis and protein degradation related
protein content
There were no changes in p-AKTser473/AKT (total)
(P = 0.15), p-mTORser2448/mTOR (Total) (P = 0.15),
p70S6K (P = 0.28), Caspase 3 (P = 0.19), p-4EBP1thr37/46
(P = 0.67), p-TSC2thr1462/TSC2 (Total) (P = 0.29),
LC3BII:I ratio (P = 0.88) or NFκB (P = 0.72) protein
content from pre- to post-intervention (Fig. 4).
Discussion
We observed a significantly lower rate of MyoPS following
5 nights of SR, whereas there was no difference in
rates of MyoPS between the SR+HIIE and NS group.
There were, however, no changes in molecular markers
that are commonly used to indicate activation of the
protein synthesis and degradation pathways. These results
provide novel insights into mechanisms underlying the
previously described decreases in muscle mass that have
been attributed to inadequate sleep, and suggest HIIE
as a potential therapeutic intervention to mitigate these
changes.
Sleep restriction, exercise and MyoPS
Rates of protein synthesis are considered the primary
driving mechanism for changes in muscle mass (atrophy
and hypertrophy) (Rennie, 1985; Gibson et al. 1987;
de Boer et al. 2007). Previous reports have shown
reductions in muscle mass when obtaining insufficient
sleep (Nedeltcheva et al. 2010; Dattilo et al. 2012; de
Sa Souza et al. 2016); however, the present study is the
first to demonstrate a lower rate of MyoPS in a SR group
following 4 h TIB for five consecutive nights. This period
of time was probably too short to detect any meaningful
reductions in muscle mass or muscle fibre cross-sectional
area (CSA). However, persistent reductions in MyoPS are
associated with the loss of muscle mass, as have been
reported with a variety of muscle disuse conditions (i.e.
step reduction, limb immobilization and bed rest) (de
Boer et al. 2007; Breen et al. 2013). As such, the lower
rate of MyoPS reported here aligns with observations
of decreases in muscle fibre CSA, reported previously in
rodents (following 96 h of sleep deprivation) (Dattilo et al.
2012; Monico-Neto et al. 2015a; de Sa Souza et al. 2016)
and increased loss of muscle mass with sleep restriction
in humans (Nedeltcheva et al. 2010). Nonetheless, further
research is needed to determine the long-term effects of
sleep restriction on both MyoPS and the maintenance
of muscle mass as there may be implications for those
populations at risk of regularly experiencing inadequate
or reduced sleep (e.g. elderly populations, shift-workers)
or those interested in the maintenance of rates of MyoPS
(e.g. athletes) (Akerstedt & Wright, 2009; Chien et al.
2015; Fullagar et al. 2016). Previous interventions where
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MyoPS is reduced in response to step reduction have
suggested the development of an ‘anabolic resistance’, such
that the amino acid-induced stimulation of MyoPS is
blunted (Breen et al. 2013). Because the SR group had
rates of MyoPS that were 19% lower than that of the
NS or SR+HIIE groups, it may be proposed that sleep
restriction can inhibit MyoPS. As such, further research
should investigate the potential effect sleep restrictionmay
have on the anabolic stimuli provided by interventions
such as feeding and exercise.
Resistance exercise is well known to increase rates of
MyoPS in skeletal muscle with subsequent increases in
Figure 3. Skeletal muscle mRNA expression of genes related to protein synthesis, degradation and
autophagy signalling pathways, normalized to pre-intervention values (i.e. values shown are fold
change from pre-intervention, calculated via the 2−Ct method). Foxo1 (A), Foxo3 (B), Myostatin (C),
Murf1 (D), Mafbx (E), Mighty (F)
NS, SR and SR+EX groups. Bars are the mean ± SD; n = 7 in NS, n = 8 in both SR and SR+EX. Individual participant
responses are indicated by individual symbols.
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muscle mass suggesting this exercise modality warrants
further investigation in the context of sleep loss (Konopka
& Harber, 2014; Brook et al. 2015; Brook et al. 2016;
Robinson et al.2017).However, increases inMyoPS(which
may also be associated with skeletal muscle remodelling)
have also been observed with endurance exercise (and
in particular, HIIE), although the findings appear to be
somewhat protocol-dependent (Di Donato et al. 2014;
Konopka &Harber, 2014). The results of the present study
demonstrate that the rate of MyoPS was higher in the
SR+EX group compared to the SR group. The higher
MyoPS observed in the SR+EX group compared to the SR
group is probably explained by aerobic exercise induced
increases in MyoPS (Miller et al. 2005; Di Donato et al.
2014; Bell et al. 2015). Indeed,Miller et al. (2005) reported
increases in MyoPS following 1 h of single-leg kicking
(67% Wmax), which remained elevated at 48 and 72 h
post-exercise. An additional group that combined normal
sleep (8 h TIB) with exercise (i.e. NS+EX) would have
allowed us to determine whether sleep restriction may
have attenuated additional exercise-induced-increases in
MyoPS similar to those reported previously with HIIE
interventions (Bell et al. 2015). However, the comparable
rates ofMyoPS in the SR+EX andNS groups support pre-
vious findings that implicate HIIE as a potent stimulus for
MyoPS.
Molecular markers of protein turnover
In the present study, there were no detectable changes
in mRNA expression or protein content of markers of
either the protein synthesis or degradation signalling
pathways (i.e. AKT-mTOR-p70S6K, UPS and autophagy
pathways). Similar to the present study, no change in
key regulators of the protein synthesis pathway (i.e.
p-mTORser2448 or p-p70S6Kthr389)were reported following
Figure 4. Skeletal muscle protein content of protein synthesis, autophagy and protein degradation
pathways
p-AKTser473/AKT (total) (A), p-mTORser2448/mTOR (total) (B), p-TSC2thr462/TSC2 (total) (C), p-4EBP1thr37/46 (D),
p70S6K (total) (E), Caspase-3 (F), LC3BII/LC3BI ratio (G), total NFκB (H) and representative western blots images (I).
Data are presented as the fold-change from pre-intervention. NS, SR and SR+EX groups. Bars are the mean ± SD;
n = 8 in each group. Individual participant responses are indicated by individual symbols.
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96 h of sleep deprivation in rats, despite reductions in
muscle fibre CSA (Monico-Neto et al. 2015a; de Sa Souza
et al. 2016). By contrast to our findings, however, these
same studies reported an increase in markers of the
UPS and autophagy signalling pathways (i.e. p-FOXO3,
LC3 and p62/SQSTM protein content) (Monico-Neto
et al. 2015a; de Sa Souza et al. 2016) indicating that
sleep deprivation increases MPB in rats. Although some
evidence supports corresponding changes in MyoPS and
its associated signalling responses (Brook et al. 2015),
dissociations similar to those reported in the present study
are not uncommon (de Boer et al. 2007; Greenhaff et al.
2008; Atherton et al. 2010). Furthermore, the absence of
changes to the MPS and MPB signalling pathways may
be explained by the transient nature of their regulation
and in relation to biopsy timing, which has previously
been demonstrated in different contexts (de Boer et al.
2007; Atherton et al. 2010). Despite not detecting changes
to markers of the MPS and MPB signalling pathways
in the present study, the D2O method for assessing
MyoPS allows for an integrated measure of MyoPS (i.e.
it represents MyoPS in the fed, fasted, exercised, sleep
and awaken states) throughout the intervention, and
also encapsulates the influence of sleep restriction and
exercise in a realistic, free-living setting, over an extended
duration.
In the context of exercise, several studies have reported
increases in phosphorylation of AKTser473, mTORser2448
and decreases in eEF2thr56 protein, immediately following
an endurance exercise session, with levels returning
to baseline within 3–4.5 h (Mascher et al. 2007; Di
Donato et al. 2014). Furthermore, althoughMPB increases
following resistance exercise, it returns to resting values
within 48 h (Phillips et al. 1997; Kumar et al. 2009). Given
our post-intervention biopsy occurred 48 h following the
final exercise session, any changes in signalling markers
may no longer have been detectable. Indeed, the pre-
sent study showed that, even in the exercise group, there
were no changes to MPS andMPB signalling. When taken
together with previous literature, this probablymeans that
changes in the molecular signalling pathways for MPS
and MPB occur during the earlier stages of the sleep
intervention or accumulated throughout the day as the
homeostatic drive for sleep increased (rather than the
hours immediately following sleep) and/or in the hours
immediately followingHIIE (deBoer et al.2007;Greenhaff
et al. 2008; Atherton et al. 2010). To fully determine
the mechanisms that may underpin the lower rates of
MyoPS observed in the SR group, and the comparable
rates of MyoPS in the SR+EX and NS groups, further
research is required with additional muscle sampling
throughout the intervention to capture early signalling
responses to exercise, feeding and changes as the duration
of wakefulness is extended.
Given the capacity for HIIE to promote MyoPS (Di
Donato et al. 2014; Bell et al. 2015) and the findings of
the present study suggesting that HIIE may be capable
of maintaining regular rates of MyoPS during periods of
sleep restriction, collectively, these data may be of interest
to populations for whom inadequate sleep is common,
and the maintenance of muscle mass is of a particular
concern (e.g. shift-workers, athletic populations, military
personnel) (Akerstedt &Wright, 2009; Fullagar et al. 2016;
Mysliwiec et al. 2016). Furthermore, the prevalence of
sarcopenia in older adults (>65 years of age) is increased
in those who report sleeping <6 h per night (Chien et al.
2015; Buchmann et al. 2016; Hu et al. 2017). Although
still speculative from the present acute data, the results of
the present study suggest that regular HIIEmay be used to
preserve muscle mass and function in these populations
and provides the foundation for future research in the
area.
Limitations
Although previous research suggests that alterations to
MyoPS underlie changes in muscle mass (Rennie, 1985;
Gibson et al. 1987; de Boer et al. 2007), the present
study did not employ direct measurements of changes in
muscle mass. Previous research has observed dual-energy
X-ray absorptiometry-derived losses in fat-free soft tissue
mass across a 14-day sleep restriction period, although
the magnitude of this effect was probably enhanced by
the calorie-restricted diet employed (Nedeltcheva et al.
2010).Nevertheless, the current interventiondurationwas
probably too short to detect changes in lean mass with
dual-energy X-ray absorptiometry (given the variability of
the measure) (Bone et al., 2017) and future investigations
of similar durations should consider incorporating direct
measures of muscle mass (i.e. with magnetic resonance
imaging or CSA). Although our data report a significantly
lower rate of MyoPS (19%) with sleep restriction, with
the present study design, it is unclear how this compares
to baseline rates of MyoPS. As such, future studies may
incorporate a baseline measurement into the study as a
comparisonmeasurement. Furthermore, as eluded to pre-
viously, the addition of a normal sleep and exercise group
may have provided further mechanistic insight into the
effect of sleep restriction and HIIE on MyoPS. Finally,
without further research that includes female and older
participants, the generalizability of these findings for the
wider population remains to be elucidated.
Conclusions
We discovered that, following five nights of sleep
restriction (4 h TIB, each night), the rate of MyoPS
was significantly lower (by 19%) compared to the NS
and SR+EX groups. To our knowledge, this is the
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
1534 N. J Saner and others J Physiol 598.8
first observation of a sleep-restriction-induced change
in MyoPS in humans. Importantly, we showed that
participants in the SR+EX group had higher rates of
MyoPS than the SR group and were similar to those in the
NS group. However, there was a dissociation between the
changes in MyoPS and the molecular signalling pathways
that regulate protein synthesis and degradation. Although
further investigations are needed, these findings suggest
that sleep restriction can have detrimental effects on the
processes that maintain muscle mass, via the potential
suppression of MyoPS. Our findings may partly help to
explain previous reports of reduced muscle mass in those
experiencing insufficient sleep (Nedeltcheva et al. 2010).
Our observation that those participants performing HIIE
during the SR intervention were able to maintain their
rates ofMyoPS at levels comparable to the NS group could
have important implications for a range of populations
experiencing inadequate sleep and lends support to the
idea that HIIE could be a viable intervention to mitigate
certain detrimental effects associated with sleep loss.
References
Akerstedt T & Wright KP, Jr (2009). Sleep loss and fatigue in
shift work and shift work disorder. Sleep Med Clin 4,
257–271.
Atherton PJ, Etheridge T, Watt PW, Wilkinson D, Selby A,
Rankin D, Smith K & Rennie MJ (2010). Muscle full effect
after oral protein: time-dependent concordance and
discordance between human muscle protein synthesis and
mTORC1 signaling. Am J Clin Nutr 92, 1080–1088.
Bell KE, Seguin C, Parise G, Baker SK & Phillips SM (2015).
Day-to-day changes in muscle protein synthesis in recovery
from resistance, aerobic, and high-intensity interval exercise
in older men. J Gerontol A Biol Sci Med Sci 70, 1024–1029.
Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL,
Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC,
Glass DJ & Yancopoulos GD (2001). Akt/mTOR pathway is a
crucial regulator of skeletal muscle hypertrophy and can
prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014–1019.
Bone JL, Ross ML, Tomcik KA, Jeacocke NA, Hopkins WG &
Burke LM (2017). Manipulation of muscle creatine and
glycogen changes dual x-ray absorptiometry estimates of
body composition. Med Sci Sports Exerc 49, 1029–1035.
Borg G (1970). [Physical training. 3. Perceived exertion in
physical work]. Lakartidningen 67, 4548–4557.
Breen L, Stokes KA, Churchward-Venne TA, Moore DR, Baker
SK, Smith K, Atherton PJ & Phillips SM (2013). Two weeks
of reduced activity decreases leg lean mass and induces
“anabolic resistance” of myofibrillar protein synthesis in
healthy elderly. J Clin Endocrinol Metab 98, 2604–2612.
Brook MS, Wilkinson DJ, Mitchell WK, Lund JN, Szewczyk NJ,
Greenhaff PL, Smith K & Atherton PJ (2015). Skeletal
muscle hypertrophy adaptations predominate in the early
stages of resistance exercise training, matching deuterium
oxide-derived measures of muscle protein synthesis and
mechanistic target of rapamycin complex 1 signaling. FASEB
J. 29, 4485–4496
Brook MS, Wilkinson DJ, Smith K & Atherton PJ (2016). The
metabolic and temporal basis of muscle hypertrophy in
response to resistance exercise. Eur J Sport Sci 16,
633–644.
Buchmann N, Spira D, Norman K, Demuth I, Eckardt R &
Steinhagen-Thiessen E (2016). Sleep, muscle mass and
muscle function in older people. Dtsch Arztebl Int 113,
253–260.
Burd NA, West DW, Staples AW, Atherton PJ, Baker JM, Moore
DR, Holwerda AM, Parise G, Rennie MJ, Baker SK & Phillips
SM (2010). Low-load high volume resistance exercise
stimulates muscle protein synthesis more than high-load low
volume resistance exercise in young men. PLoS One 5,
e12033.
Chien MY, Wang LY & Chen HC (2015). The relationship of
sleep duration with obesity and sarcopenia in
community-dwelling older adults. Gerontology 61, 399–406.
Dattilo M, Antunes HK, Medeiros A, Monico-Neto M, Souza
Hde S, Lee KS, Tufik S & de Mello MT (2012). Paradoxical
sleep deprivation induces muscle atrophy. Muscle Nerve 45,
431–433.
de Boer MD, Selby A, Atherton P, Smith K, Seynnes OR,
Maganaris CN, Maffulli N, Movin T, Narici MV & Rennie
MJ (2007). The temporal responses of protein synthesis,
gene expression and cell signalling in human quadriceps
muscle and patellar tendon to disuse. J Physiol 585,
241–251.
de Sa Souza H, Antunes HK, Dattilo M, Lee KS, Monico-Neto
M, de Campos Giampa SQ, Phillips SM, Tufik S & de Mello
MT (2016). Leucine supplementation is anti-atrophic during
paradoxical sleep deprivation in rats. Amino Acids 48,
949–957.
Di Donato DM, West DW, Churchward-Venne TA, Breen L,
Baker SK & Phillips SM (2014). Influence of aerobic exercise
intensity on myofibrillar and mitochondrial protein
synthesis in young men during early and late postexercise
recovery. Am J Physiol Endocrinol Metab 306, E1025–E1032.
Duffy JF & Wright KP, Jr (2005). Entrainment of the human
circadian system by light. J Biol Rhythms 20, 326–338.
Ford ES, Cunningham TJ & Croft JB (2015). Trends in
self-reported sleep duration among US adults from 1985 to
2012. Sleep 38, 829–832.
Fullagar HH, Skorski S, Duffield R, Julian R, Bartlett J & Meyer
T (2016). Impaired sleep and recovery after night matches in
elite football players. J Sports Sci 34, 1333–1339.
Gibson JN, Halliday D, Morrison WL, Stoward PJ, Hornsby
GA, Watt PW, Murdoch G & Rennie MJ (1987). Decrease in
human quadriceps muscle protein turnover consequent
upon leg immobilization. Clin Sci (Lond) 72, 503–509.
Granata C, Oliveira RS, Little JP, Renner K & Bishop DJ (2016).
Training intensity modulates changes in PGC-1alpha and
p53 protein content and mitochondrial respiration, but not
markers of mitochondrial content in human skeletal muscle.
FASEB J 30, 959–970.
Greenhaff PL, Karagounis LG, Peirce N, Simpson EJ, Hazell M,
Layfield R, Wackerhage H, Smith K, Atherton P, Selby A &
Rennie MJ (2008). Disassociation between the effects of
amino acids and insulin on signaling, ubiquitin ligases, and
protein turnover in human muscle. Am J Physiol Endocrinol
Metab 295, E595–E604.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
J Physiol 598.8 The effect of sleep restriction and exercise on myofibrillar protein synthesis 1535
Hector AJ, McGlory C, Damas F, Mazara N, Baker SK &
Phillips SM (2018). Pronounced energy restriction with
elevated protein intake results in no change in proteolysis
and reductions in skeletal muscle protein synthesis that are
mitigated by resistance exercise. FASEB J 32, 265–275.
Hochsmann C, Knaier R, Eymann J, Hintermann J, Infanger D
& Schmidt-Trucksass A (2018). Validity of activity trackers,
smartphones, and phone applications to measure steps in
various walking conditions. Scand J Med Sci Sports 28,
1818–1827.
Hood MS, Little JP, Tarnopolsky MA, Myslik F & Gibala MJ
(2011). Low-volume interval training improves muscle
oxidative capacity in sedentary adults. Med Sci Sports Exerc
43, 1849–1856.
Hu X, Jiang J, Wang H, Zhang L, Dong B & Yang M (2017).
Association between sleep duration and sarcopenia among
community-dwelling older adults: a cross-sectional study.
Medicine (Baltimore) 96, e6268.
Kant GJ, Genser SG, Thorne DR, Pfalser JL & Mougey EH
(1984). Effects of 72 h sleep deprivation on urinary cortisol
and indices of metabolism. Sleep 7, 142–146.
Konopka AR &Harber MP (2014). Skeletal muscle hypertrophy
after aerobic exercise training. Exerc Sport Sci Rev 42, 53–61.
Kosmadopoulos A, Sargent C, Darwent D, Zhou X & Roach
GD (2014). Alternatives to polysomnography (PSG): a
validation of wrist actigraphy and a partial-PSG system.
Behav Res Methods 46, 1032–1041.
Kuang J, Yan X, Genders AJ, Granata C & Bishop DJ (2018). An
overview of technical considerations when using quantitative
real-time PCR analysis of gene expression in human exercise
research. PLoS One 13, e0196438.
Kumar V, Atherton P, Smith K & Rennie MJ (2009). Human
muscle protein synthesis and breakdown during and after
exercise. J Appl Physiol (1985) 106, 2026–2039.
Little JP, Gillen JB, Percival ME, Safdar A, Tarnopolsky MA,
Punthakee Z, Jung ME & Gibala MJ (2011). Low-volume
high-intensity interval training reduces hyperglycemia and
increases muscle mitochondrial capacity in patients with
type 2 diabetes. J Appl Physiol (1985) 111, 1554–1560.
Little JP, Safdar A, Wilkin GP, Tarnopolsky MA & Gibala MJ
(2010). A practical model of low-volume high-intensity
interval training induces mitochondrial biogenesis in human
skeletal muscle: potential mechanisms. J Physiol-London 588,
1011–1022.
Mascher H, Andersson H, Nilsson PA, Ekblom B & Blomstrand
E (2007). Changes in signalling pathways regulating protein
synthesis in human muscle in the recovery period after
endurance exercise. Acta Physiol (Oxf) 191, 67–75.
McGlory C, von Allmen MT, Stokes T, Morton RW, Hector AJ,
Lago BA, Raphenya AR, Smith BK, McArthur AG, Steinberg
GR, Baker SK & Phillips SM (2018). Failed recovery of
glycemic control and myofibrillar protein synthesis with 2
wk of physical inactivity in overweight, prediabetic older
adults. J Gerontol A Biol Sci Med Sci 73, 1070–1077.
Miller BF, Olesen JL, Hansen M, Dossing S, Crameri RM,
Welling RJ, Langberg H, Flyvbjerg A, Kjaer M, Babraj JA,
Smith K & Rennie MJ (2005). Coordinated collagen and
muscle protein synthesis in human patella tendon and
quadriceps muscle after exercise. J Physiol 567, 1021–1033.
Monico-Neto M, Antunes HK, Lee KS, Phillips SM, Giampa
SQ, Souza Hde S, Dattilo M, Medeiros A, de Moraes WM,
Tufik S & de Mello MT (2015a). Resistance training
minimizes catabolic effects induced by sleep deprivation in
rats. Appl Physiol Nutr Metab 40, 1143–1150.
Monico-Neto M, Giampa SQ, Lee KS, de Melo CM, Souza Hde
S, Dattilo M, Minali PA, Santos Prado PH, Tufik S, de Mello
MT & Antunes HK (2015b). Negative energy balance
induced by paradoxical sleep deprivation causes
multicompartmental changes in adipose tissue and skeletal
muscle. Int J Endocrinol 2015, 908159.
Murphy RM & Lamb GD (2013). Important considerations for
protein analyses using antibody based techniques:
down-sizing western blotting up-sizes outcomes.
J Physiol-London 591, 5823–5831.
Mysliwiec V, Walter RJ, Collen J & Wesensten N (2016).
Military sleep management: an operational imperative. US
Army Med Dep J, 128–134.
National Sleep Foundation (2015). National Sleep Foundation
Recommends New Sleep Times, ed. Duggan A.
Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA &
Penev PD (2010). Insufficient sleep undermines dietary
efforts to reduce adiposity. Ann Intern Med 153,
435–441.
Oakley N (1997). Validation with polysomnography of the
Sleepwatch sleep/wake scoring algorithm used by the
Actiwatch activity monitoring system. Bend: Mini Mitter,
Cambridge Neurotechnology.
Phillips SM, Tipton KD, Aarsland A, Wolf SE & Wolfe RR
(1997). Mixed muscle protein synthesis and breakdown after
resistance exercise in humans. Am J Physiol Endocrinol Metab
273, E99–E107.
Rennie MJ (1985). Muscle protein turnover and the wasting
due to injury and disease. Br Med Bull 41, 257–264.
Reynolds AC, Dorrian J, Liu PY, Van Dongen HP, Wittert GA,
Harmer LJ & Banks S (2012). Impact of five nights of sleep
restriction on glucose metabolism, leptin and testosterone in
young adult men. PLoS One 7, e41218.
Robinson MM, Dasari S, Konopka AR, Johnson ML,
Manjunatha S, Esponda RR, Carter RE, Lanza IR & Nair KS
(2017). Enhanced protein translation underlies improved
metabolic and physical adaptations to different exercise
training modes in young and old humans. Cell Metab 25,
581–592.
Rudrappa SS, Wilkinson DJ, Greenhaff PL, Smith K, Idris I &
Atherton PJ (2016). Human skeletal muscle disuse atrophy:
effects on muscle protein synthesis, breakdown, and insulin
resistance – a qualitative review. Front Physiol
7, 361.
Saner NJ, Bishop DJ & Bartlett JD (2018). Is exercise a viable
therapeutic intervention to mitigate mitochondrial
dysfunction and insulin resistance induced by sleep loss?
Sleep Med Rev 37, 60–68.
Sargent C, Lastella M, Halson SL & Roach GD (2016). The
validity of activity monitors for measuring sleep in elite
athletes. J Sci Med Sport 19, 848–853.
Schmittgen TD & Livak KJ (2008). Analyzing real-time PCR
data by the comparative C-T method. Nat Protoc 3,
1101–1108.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
1536 N. J Saner and others J Physiol 598.8
Spiegel K, Leproult R & Van Cauter E (1999). Impact of sleep
debt on metabolic and endocrine function. Lancet 354,
1435–1439.
Symons TB, Sheffield-Moore M, Chinkes DL, Ferrando AA &
Paddon-Jones D (2009). Artificial gravity maintains skeletal
muscle protein synthesis during 21 days of simulated
microgravity. J Appl Physiol (1985) 107,
34–38.
Tipton KD, Hamilton DL & Gallagher IJ (2018). Assessing the
role of muscle protein breakdown in response to nutrition
and exercise in humans. Sports Med 48,
53–64.
Van Dongen HP, Maislin G, Mullington JM & Dinges DF
(2003). The cumulative cost of additional wakefulness:
dose-response effects on neurobehavioral functions and
sleep physiology from chronic sleep restriction and total
sleep deprivation. Sleep 26, 117–126.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N,
De Paepe A & Speleman F (2002). Accurate normalization of
real-time quantitative RT-PCR data by geometric averaging
of multiple internal control genes. Genome Biol 3.
Wilkinson DJ, Franchi MV, Brook MS, Narici MV, Williams JP,
Mitchell WK, Szewczyk NJ, Greenhaff PL, Atherton PJ &
Smith K (2014). A validation of the application of D(2)O
stable isotope tracer techniques for monitoring day-to-day
changes in muscle protein subfraction synthesis in humans.
Am J Physiol Endocrinol Metab 306, E571–E579.
Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S &
Madden TL (2012). Primer-BLAST: a tool to design
target-specific primers for polymerase chain reaction. BMC
Bioinformatics 13, 134.
Additional information
Competing interests
The authors declare that they have no competing interests.
Author contributions
NS, GR, SP, DB and JB were involved in the conception and
designof thepresent study.NS,ML,NP,AG,TS, JK, SP,DBand JB
were involved in the acquisition, analysis or interpretation of the
data. NS, ML, NP, AG, GR, TS, JK, SP, DB and JB were involved
in drafting the work and revising it critically for important
intellectual content. All authors approved the final version of the
manuscript submitted for publication. All authors agree to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved. All persons designated
as authors qualify for authorship, and all those who qualify for
authorship are listed.
Funding
This publication was supported in part by a Sports Medicine
Australia (SMA) Research Foundation Grant and Australian
Postgraduate Award PhD Scholarship to NS. SMP gratefully
acknowledges support from the Canada Research Chairs
program and the funding for this work provided by the National
Science and Engineering Research Council (NSERC) of Canada.
TSwas supported by anNSERC of Canada graduate scholarship.
Acknowledgements
We thank all of the participants for their willingness to be
involved with this study. We acknowledge the assistance of
Dwight Marinkovic during data collection, as well as Conor
Verbruggen and Dr Chris McGlory throughout the analysis
process.
Keywords
atrophy, high-intensity interval exercise, protein synthesis, sleep
loss
Supporting information
Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Statistical Summary Document
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
